{
    "2019-04-09": [
        [
            {
                "time": "",
                "original_text": "刚辟谣虚增利润又收问询函 华大基因麻烦不断",
                "features": {
                    "keywords": [
                        "虚增利润",
                        "问询函",
                        "华大基因",
                        "麻烦"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因一季度营收预增10%-20% 净利润因研发投入加大基本持平",
                "features": {
                    "keywords": [
                        "华大基因",
                        "一季度",
                        "营收增长",
                        "研发投入",
                        "净利润持平"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)一季度预盈9500万元–10500万元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "一季度",
                        "预盈",
                        "9500万元-10500万元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：一季度净利0.95–1.05亿 同比减5.7%-4.2%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "一季度",
                        "净利下降",
                        "同比减少"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：一季度净利同比基本持平",
                "features": {
                    "keywords": [
                        "华大基因",
                        "一季度",
                        "净利持平"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：预计一季度盈利变动区间为-5.71%-4.22%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "一季度",
                        "盈利变动",
                        "-5.71%-4.22%"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因涉嫌虚增利润被问询 欺诈造假",
                "features": {
                    "keywords": [
                        "华大基因",
                        "虚增利润",
                        "问询",
                        "欺诈造假"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "陷虚增利润、违规关联交易舆论漩涡 深交所向华大基因出具问询函 其他违规处罚",
                "features": {
                    "keywords": [
                        "华大基因",
                        "虚增利润",
                        "违规关联交易",
                        "问询函",
                        "违规处罚"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "5天内两收监管质疑 华大基因能否 靠测序仪“翻身”？其他违规处罚",
                "features": {
                    "keywords": [
                        "华大基因",
                        "监管质疑",
                        "测序仪",
                        "翻身",
                        "违规处罚"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}